Rat diaphragm cyclic nucleotide-phosphodiesterase: influence of drugs affecting skeletal muscle contractility.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D000242:Cyclic AMP; D006152:Cyclic GMP / Q000494:pharmacology; D003956:Dialysis; D003964:Diaphragm / Q000201:enzymology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007292:Inosine Nucleotides / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000201:enzymology*; D009711:Nucleotides; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000302:isolation & purification; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology; D014500:Uracil Nucleotides / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology
D007292:Inosine Nucleotides; D009711:Nucleotides; D010726:Phosphodiesterase Inhibitors; D014500:Uracil Nucleotides; D014970:Xanthines; D006852:Hydrochlorothiazide; D003994:Bucladesine; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP; D014403:Tubocurarine